Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20240529061938N1Phase 3Completed
Phase 3 trial of metronidazole in trichomoniasis (trich) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Clinical and microbiological cure of Trichomonas vaginalis infection. Started Jul 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20240529061938N1.